skip to Main Content

Precision Medicine Enablement via Advanced Diagnostics Workgroup

Precision Medicine Enablement via Advanced Diagnostics

  • Fully integrate PGx services into the pharmaceutical care process to support useful clinical decision making through increased availability of data.
  • Ensure providers and payors have secure and timely access to the information necessary to identify patients who have not achieved clinical goals of therapy.
  • Optimize testing usefulness and interpretation by strengthening the relationship between the FDA and laboratories that provide PGx testing.
  • Promote precision medicine literacy among providers and patients in the context of its application to the clinical care role in optimizing medication use.
  • Enable evidence-based processes and strategies that support precision medicine as a tool used in the CMM process and enable effective standardization, awareness and interpretation.

Did you miss the November Call for Member Feedback? Watch the recordings here.

Workshop Co-Leads

Brian Caveney pic

Co-Lead: Brian Caveney, MD, JD, MPH, President, Enterprise-Wide Chief Medical Officer, Labcorp


Jill Bates headshot

Co-Lead: Jill Bates, PharmD, MS, BCOP, FASHP, PHASER Pharmacy Program Manager, Durham VA Health Care System; Associate Professor of Clinical Education, UNC Eshelman School of Pharmacy

  • Areas of Further Work
  • Workgroup Participants

Areas of Further Work

  1. Regulation: Strengthen the relationship of the FDA with laboratories that provide pharmacogenomic testing to optimize its usefulness to patients and providers
  2. HIT and AI: Develop tools that enable the practice of precision medicine and advanced diagnostics?
  3. Marketplace Strategy: Create and implement a plan that promotes precision medicine literacy and application to clinical care
  4. Education and Public Awareness: Standardize a process for precision medicine care and support providers in its delivery and adoption
  5. Evidence-Based Process: Create an evidence-based process that supports precision medicine data and enables effective understanding, awareness and interpretation

Workgroup Participants

  • Marcia Eisenberg, PhD, Chief Scientific Officer, Senior Vice President, LabCorp
  • Steve Anderson, PhD, Chief Scientific Officer-Covance, Senior Vice President, LabCorp
  • Tom Kraus, JD, MHS, Vice President, Office of Government Relations, American Society of Health-System Pharmacists
  • Jacques Turgeon, BPharm, PhD, Chief Scientific Officer, Tabula Rasa; CEO, Precision Pharmacotherapy Research and Development Institute
  • Dorothy (DotAdcock, MD, Chief Medical Officer and Senior Vice President, LabCorp
  • Anthony Morreale, PharmD, MBA, BCPS, FASHP, Associate Chief Consultant for Clinical Pharmacy Services & Policy, Pharmacy Benefits Management VACO
  • Chet Robson, DO, MHCDS, FAAFP, Medical Director, Walgreens Co.
  • Philip Empey, PharmD, PhD, Director, PGx Center of Excellence; Associate Director, Institute for Precision Medicine; Associate Professor, Dept. of Pharmacy and Therapeutics, Center for Clinical Pharmaceutical Sciences
    and the Clinical and Translational Science Institute
  • Jane Gilbert, CPA, Director, Retiree Health Care, Kentucky Teachers’ Retirement System
  • Sarah Mallak, PharmD, Director, Clinical Product Design & Strategy, Genoa Healthcare
  • Julie Ceno-England, MD, Interim Chief Medical Officer, OneOme
  • Amber Cipriani, PharmD, BCOP, CPP, Precision Medicine Pharmacy Coordinator, UNC Medical Center; Clinical Assistant Professor, UNC Eshelman School of Pharmacy
  • Cyrine-Eliana Haidar, Pharm.D., BCPS, BCOP, Clinical Pharmacogenetics Coordinator, St. Jude Children’s Research Hospital

Learn More

For more information about the workgroup or membership contact:

Izzy Serji
Operations Manager

Back To Top
×Close search

We need your help now more than ever!